Roche's HCV assay for new platforms:
This article was originally published in Clinica
Roche Diagnostics has CE marked its Elecsys anti-hepatitis-C virus assay for sale in Europe. It may now be used with the E 170 analyser for modular analytics and the e 601 module for the cobas 6000 platform. The assay is already available on the Elecsys 2010 and cobas e 411 instruments. The Swiss company's Elecsys product line, based on electrochemiluminescence technology, has other assays covering cardiac, bone and tumour markers, among others.
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”